in-Pharmatechnologist.com is here to see AstraZeneca’s Turbuhaler production facility. The plant produces a large number of inhalers at a range of dosages for markets worldwide, which poses significant packaging, labelling and logistics challenges.
Crosslinking is a natural phenomenon occurring in gelatin that negatively impacts soft capsules, reducing their stability and prolonging their dissolution...
Content provided by Catalent Pharma Solutions | 19-Oct-2023
| Business Advice
New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...
Content provided by Lonza Capsules & Health Ingredients | 01-Sep-2023
| White Paper
Invivo: Many orally dosed APIs are bioavailable only when formulated as an enteric dosage form to protect them from the harsh environment of the stomach....